{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T05:27:54Z","timestamp":1787635674946,"version":"build-2736575974"},"reference-count":36,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2022,1,19]],"date-time":"2022-01-19T00:00:00Z","timestamp":1642550400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,4,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>Quantitative (e.g. increasing recreational cannabinoid use) and qualitative (e.g. increasing availability and use of synthetic cannabinoids and cannabis preparations with increased tetrahydrocannabinol content) changes in cannabinoid use may be associated with changes in the prevalence of cannabinoid-related mental and behavioural disorders and, accordingly, changes in the need for medical care. We aimed to investigate if there are changes in the number of inpatient cases (ICs) due to cannabinoid-related disorders in Germany.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>Data were obtained from the Federal Statistical Office of Germany (Destatis) and comprised type and number of hospital main diagnoses (according to ICD-10) of all ICs in Germany in the period 2000\u201318. Linear trend analysis of absolute and relative annual frequencies (AFs) of ICs with diagnoses related to the use of cannabinoids (DRUCs), and, as controls, alcohol-related psychiatric disorders and schizophrenia-spectrum disorders was performed.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Absolute AFs of ICs with DRUCs increased statistically significantly (P&amp;lt;0.0001, trend analysis) in Germany between 2000 and 2018 and corresponding relative AFs increased considerably (4.8-fold increase when comparing 2000 and 2018). Specifically, absolute AFs of ICs with cannabinoid intoxications (P&amp;lt;0.0001), harmful use (P=0.0005), dependence syndrome (P&amp;lt; 0.0001), withdrawal state (P&amp;lt;0.0001), psychotic disorders (P&amp;lt; 0.0001) and residual and late-onset psychotic disorder (P&amp;lt;0.0001) statistically significantly increased. Absolute AFs of schizophrenia-spectrum disorders slightly, but statistically significantly decreased (P=0.008), and alcohol dependence did not statistically significantly change (P=0.844).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>Our evaluation demonstrates increasing numbers of ICs with mental and behavioural disorders due to use of cannabinoids in Germany and emphasizes the need for adequate prevention of such disorders.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/eurpub\/ckab207","type":"journal-article","created":{"date-parts":[[2021,11,24]],"date-time":"2021-11-24T12:13:19Z","timestamp":1637755999000},"page":"239-245","source":"Crossref","is-referenced-by-count":15,"title":["Incidence of inpatient cases with mental disorders due to use of cannabinoids in Germany: a nationwide evaluation"],"prefix":"10.1093","volume":"32","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1383-4691","authenticated-orcid":false,"given":"Maximilian","family":"Gahr","sequence":"first","affiliation":[{"name":"Department of Psychiatry and Psychotherapy III, University of Ulm, Ulm, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Ziller","sequence":"additional","affiliation":[{"name":"Department of Psychiatry and Psychotherapy III, University of Ulm, Ulm, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ferdinand","family":"Keller","sequence":"additional","affiliation":[{"name":"Department of Child and Adolescent Psychiatry and Psychotherapy, University of Ulm, Ulm, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rainer","family":"Muche","sequence":"additional","affiliation":[{"name":"Institute of Epidemiology and Medical Biometry, University of Ulm, Ulm, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulrich W","family":"Preuss","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, Psychotherapy and Psychosomatics, University Hospital Halle (Saale), Halle, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos","family":"Sch\u00f6nfeldt-Lecuona","sequence":"additional","affiliation":[{"name":"Department of Psychiatry and Psychotherapy III, University of Ulm, Ulm, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2022,1,19]]},"reference":[{"key":"2022040215410791900_ckab207-B1","year":"2019"},{"key":"2022040215410791900_ckab207-B2","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1080\/10826080701884911","article-title":"Understanding the motivations for recreational marijuana use among adult Canadians","volume":"43","author":"Osborne","year":"2008","journal-title":"Subst Use Misuse"},{"key":"2022040215410791900_ckab207-B3","volume-title":"Cannabis in Medical Practice: A Legal, Historical, and Pharmacological Overview of the Therapeutic Use of Marijuana","author":"Mathre","year":"1997"},{"key":"2022040215410791900_ckab207-B4","doi-asserted-by":"crossref","first-page":"2456","DOI":"10.1001\/jama.2015.6358","article-title":"Cannabinoids for medical use: a systematic review and meta-analysis","volume":"313","author":"Whiting","year":"2015","journal-title":"JAMA"},{"key":"2022040215410791900_ckab207-B5","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1016\/S2215-0366(19)30401-8","article-title":"Cannabinoids for the treatment of mental disorders and symptoms of mental disorders: a systematic review and meta-analysis","volume":"6","author":"Black","year":"2019","journal-title":"Lancet Psychiatry"},{"key":"2022040215410791900_ckab207-B6","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1016\/j.euroneuro.2018.10.004","article-title":"Spicing it up \u2013 synthetic cannabinoid receptor agonists and psychosis \u2013 a systematic review","volume":"28","author":"Hobbs","year":"2018","journal-title":"Eur Neuropsychopharmacol"},{"key":"2022040215410791900_ckab207-B7","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1016\/S0140-6736(98)05021-1","article-title":"Adverse effects of cannabis","volume":"352","author":"Hall","year":"1998","journal-title":"Lancet"},{"key":"2022040215410791900_ckab207-B8","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1038\/nrcardio.2017.130","article-title":"Cardiovascular effects of marijuaa and synthetic cannabinoids: the good, the bad, and the ugly","volume":"15","author":"Pacher","year":"2018","journal-title":"Nat Rev Cardiol"},{"key":"2022040215410791900_ckab207-B9","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.forsciint.2019.03.007","article-title":"Cannabis as a cause of death: a review","volume":"298","author":"Drummer","year":"2019","journal-title":"Forensic Sci Int"},{"key":"2022040215410791900_ckab207-B10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1001\/jamapsychiatry.2021.1258","article-title":"Association of cannabis use during adolescence with neurodevelopment","volume":"78","author":"Albaugh","year":"2021","journal-title":"JAMA Psychiatry"},{"key":"2022040215410791900_ckab207-B11","doi-asserted-by":"crossref","first-page":"e710","DOI":"10.1038\/tp.2015.201","article-title":"Hippocampal harms, protection and recovery following regular cannabis use","volume":"6","author":"Y\u00fccel","year":"2016","journal-title":"Transl Psychiatry"},{"key":"2022040215410791900_ckab207-B12","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1001\/jamapsychiatry.2018.0335","article-title":"Association of cannabis with cognitive functioning in adolescents and young adults: a systematic review and meta-analysis","volume":"75","author":"Scott","year":"2018","journal-title":"JAMA Psychiatry"},{"key":"2022040215410791900_ckab207-B13","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1176\/appi.ajp.2015.15070907","article-title":"Prevalence and correlates of DSM-5 cannabis use disorder, 2012\u20132013: findings from the National Epidemiologic Survey on Alcohol and Related Conditions-III","volume":"173","author":"Hasin","year":"2016","journal-title":"Am J Psychiatry"},{"key":"2022040215410791900_ckab207-B14","doi-asserted-by":"crossref","first-page":"S14","DOI":"10.1038\/525S14a","article-title":"Perspective: be clear about the real risks","volume":"525","author":"Hill","year":"2015","journal-title":"Nature"},{"key":"2022040215410791900_ckab207-B15","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/j.biopsych.2016.02.005","article-title":"Cannabis and psychosis: what degree of proof do we require?","volume":"79","author":"Murray","year":"2016","journal-title":"Biol Psychiatry"},{"key":"2022040215410791900_ckab207-B16","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1080\/00952990.2019.1569668","article-title":"Time trends in US cannabis use and cannabis use disorders overall and by sociodemographic subgroups: a narrative review and new findings","volume":"45","author":"Hasin","year":"2019","journal-title":"Am J Drug Alcohol Abuse"},{"key":"2022040215410791900_ckab207-B17","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1038\/npp.2017.198","article-title":"US epidemiology of cannabis use and associated problems","volume":"43","author":"Hasin","year":"2018","journal-title":"Neuropsychopharmacology"},{"key":"2022040215410791900_ckab207-B18","author":"Orth","year":"2019"},{"key":"2022040215410791900_ckab207-B19","doi-asserted-by":"crossref","first-page":"101351","DOI":"10.1016\/j.pmedr.2021.101351","article-title":"Trends in youth cannabis use across cannabis legalization: data from the COMPASS prospective cohort study","volume":"22","author":"Zuckermann","year":"2021","journal-title":"Prev Med Rep"},{"key":"2022040215410791900_ckab207-B20","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.copsyc.2021.03.005","article-title":"Trends over time in adult cannabis use: a review of recent findings","volume":"38","author":"Hasin","year":"2021","journal-title":"Curr Opin Psychol"},{"key":"2022040215410791900_ckab207-B21","first-page":"585","article-title":"Trends in substance use and related disorders-analysis of the Epidemiological Survey of Substance Abuse 1995 to 2018","volume":"116","author":"Seitz","year":"2019","journal-title":"Dtsch Arztebl Int"},{"key":"2022040215410791900_ckab207-B22","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1007\/s00103-019-02962-6","article-title":"Cannabis for medical purposes-the law of March 2017 and its history","volume":"62","author":"Cremer-Schaeffer","year":"2019","journal-title":"Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz"},{"key":"2022040215410791900_ckab207-B23","first-page":"1","article-title":"Trends in cannabis-related attitudes and behaviors among cannabis \u2013 using adolescents and young adult outpatients following medical cannabis legalization","author":"O\u2019Connell","year":"2021","journal-title":"Subst Abus"},{"key":"2022040215410791900_ckab207-B24","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s42238-021-00064-2","article-title":"The frequency distribution of reported THC concentrations of legal cannabis flower products increases discontinuously around the 20% threshold in Nevada and Washington state","volume":"3","author":"Zoorob","year":"2021","journal-title":"J Cannabis Res"},{"key":"2022040215410791900_ckab207-B25","doi-asserted-by":"crossref","first-page":"106478","DOI":"10.1016\/j.addbeh.2020.106478","article-title":"Historical trends of admitted patients by selected substances and their significant patient's level factors","volume":"109","author":"Mazumder","year":"2020","journal-title":"Addict Behav"},{"key":"2022040215410791900_ckab207-B26","doi-asserted-by":"publisher","DOI":"10.1002\/acr.24752","article-title":"Increase in cannabis use among adults with rheumatic diseases: results from a 2014\u20132019 US observational study","author":"Wipfler","year":"2021","journal-title":"Arthritis Care Res"},{"key":"2022040215410791900_ckab207-B27","doi-asserted-by":"crossref","first-page":"e219375","DOI":"10.1001\/jamanetworkopen.2021.9375","article-title":"Prevalence of medical cannabis use and associated health conditions documented in electronic health records among primary care patients in Washington State","volume":"4","author":"Matson","year":"2021","journal-title":"JAMA Netw Open"},{"key":"2022040215410791900_ckab207-B28","doi-asserted-by":"crossref","first-page":"108227","DOI":"10.1016\/j.drugalcdep.2020.108227","article-title":"Cannabis use, other drug use, and risk of subsequent acute care in primary care patients","volume":"216","author":"Matson","year":"2020","journal-title":"Drug Alcohol Depend"},{"key":"2022040215410791900_ckab207-B29","doi-asserted-by":"crossref","first-page":"795","DOI":"10.3122\/jabfm.2017.06.170062","article-title":"Frequency of cannabis use among primary care patients in Washington State","volume":"30","author":"Lapham","year":"2017","journal-title":"J Am Board Fam Med"},{"key":"2022040215410791900_ckab207-B30","doi-asserted-by":"crossref","first-page":"2219","DOI":"10.1056\/NEJMra1402309","article-title":"Adverse health effects of marijuana use","volume":"370","author":"Volkow","year":"2014","journal-title":"N Engl J Med"},{"key":"2022040215410791900_ckab207-B31","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.jadohealth.2017.12.010","article-title":"Impact of marijuana legalization in Colorado on adolescent emergency and urgent care visits","volume":"63","author":"Wang","year":"2018","journal-title":"J Adolesc Health"},{"key":"2022040215410791900_ckab207-B32","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.genhosppsych.2019.08.003","article-title":"Cannabis use and psychiatric illness in the context of medical marijuana legalization: a clinical perspective","volume":"61","author":"Yuan","year":"2019","journal-title":"Gen Hosp Psychiatry"},{"key":"2022040215410791900_ckab207-B33","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1007\/s00204-013-1029-1","article-title":"Toxicological profiles of selected synthetic cannabinoids showing high binding affinities to the cannabinoid receptor subtype CB1","volume":"87","author":"Koller","year":"2013","journal-title":"Arch Toxicol"},{"key":"2022040215410791900_ckab207-B34","doi-asserted-by":"crossref","first-page":"11476","DOI":"10.1021\/acs.analchem.6b02600","article-title":"Detection and activity profiling of synthetic cannabinoids and their metabolites with a newly developed bioassay","volume":"88","author":"Cannaert","year":"2016","journal-title":"Anal Chem"},{"key":"2022040215410791900_ckab207-B35","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1007\/s13181-016-0571-7","article-title":"Acute toxicity associated with use of 5F-derivations of synthetic cannabinoid receptor agonists with analytical confirmation","volume":"12","author":"Abouchedid","year":"2016","journal-title":"J Med Toxicol"},{"key":"2022040215410791900_ckab207-B36","first-page":"82","article-title":"Intoxication from the novel synthetic cannabinoids AB-PINACA and ADB-PINACA: a case series and review of the literature","volume":"134","author":"Armenian","year":"2018","journal-title":"Neuropsychopharmacology"}],"container-title":["European Journal of Public Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/eurpub\/advance-article-pdf\/doi\/10.1093\/eurpub\/ckab207\/42237377\/ckab207.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/eurpub\/article-pdf\/32\/2\/239\/43245507\/ckab207.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/eurpub\/article-pdf\/32\/2\/239\/43245507\/ckab207.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,2]],"date-time":"2022-04-02T15:41:31Z","timestamp":1648914091000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/eurpub\/article\/32\/2\/239\/6511321"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,19]]},"references-count":36,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2022,1,19]]},"published-print":{"date-parts":[[2022,4,1]]}},"URL":"https:\/\/doi.org\/10.1093\/eurpub\/ckab207","relation":{},"ISSN":["1101-1262","1464-360X"],"issn-type":[{"value":"1101-1262","type":"print"},{"value":"1464-360X","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2022,4,1]]},"published":{"date-parts":[[2022,1,19]]}}}